Join
Live feed
·
PRReleasevia Quantisnow
Invivyd Inc. logo

Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

ByQuantisnow·Wall Street's wire, on your screen.
IVVD· Invivyd Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IVVD (Invivyd Inc.) and more on Quantisnow.